These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11279947)

  • 41. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
    Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
    Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.
    Kobak KA; Greist JH; Jefferson JW; Katzelnick DJ
    J Clin Psychopharmacol; 2002 Jun; 22(3):257-62. PubMed ID: 12006895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial.
    Asadollahi M; Ramezani M; Khanmoradi Z; Karimialavijeh E
    Clin Rehabil; 2018 Aug; 32(8):1069-1075. PubMed ID: 29783900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
    Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
    J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.
    Devanand DP; Nobler MS; Cheng J; Turret N; Pelton GH; Roose SP; Sackeim HA
    Am J Geriatr Psychiatry; 2005 Jan; 13(1):59-68. PubMed ID: 15653941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
    Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
    JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.
    Dennis M; Forbes J; Graham C; Hackett M; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G
    Health Technol Assess; 2020 May; 24(22):1-94. PubMed ID: 32452356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
    Ferrari MD; Diener HC; Ning X; Galic M; Cohen JM; Yang R; Mueller M; Ahn AH; Schwartz YC; Grozinski-Wolff M; Janka L; Ashina M
    Lancet; 2019 Sep; 394(10203):1030-1040. PubMed ID: 31427046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
    Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS
    Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study.
    Kara H; Aydin S; Yücel M; Agargün MY; Odabaş O; Yilmaz Y
    J Urol; 1996 Nov; 156(5):1631-2. PubMed ID: 8863556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. S-fluoxetine.
    Drugs R D; 1999 Dec; 2(6):392. PubMed ID: 10763449
    [No Abstract]   [Full Text] [Related]  

  • 55. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Canadian Headache Society guideline for migraine prophylaxis.
    Pringsheim T; Davenport W; Mackie G; Worthington I; Aubé M; Christie SN; Gladstone J; Becker WJ;
    Can J Neurol Sci; 2012 Mar; 39(2 Suppl 2):S1-59. PubMed ID: 22683887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
    Ashina M; Goadsby PJ; Dodick DW; Tepper SJ; Xue F; Zhang F; Brennan F; Paiva da Silva Lima G
    JAMA Neurol; 2022 Feb; 79(2):159-168. PubMed ID: 34928306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
    J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.
    Adelman LC; Adelman JU; Von Seggern R; Mannix LK
    Headache; 2000; 40(7):572-80. PubMed ID: 10940096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.